News Story: Full Text
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website

 

Defeat DIPG Executive Director Jenny Mosier Speaks at FDA Public Hearing Regarding ONC201

Al's Comment:

 This is one of the most moving speeches about how devastating pediatric brain tumors are and the need to speed up development of treatments.


Posted on: 07/01/2019

Defeat DIPG Executive Director Jenny Mosier Speaks at FDA Public Hearing Regarding ONC201 

 


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740